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Abstract
Background: This paper presents the first comprehensive effort to provide an overview of the research associated
with the World Health Organization (WHO) headquarters in 2006/07.
Methods: Information was obtained by questionnaire and interviews with senior staff operating at WHO
headquarters in Geneva. Research type, purpose and resources (both financial and staff) were defined and
compared for each of the 37 departments identified and a comparative analysis was made with the global burden
of disease as expressed by Disability Adjusted Life Years (DALY).
Results: Research expenditure in 2006/07 was estimated at US$215 million. WHO is involved in more than 60
research networks/partnerships and often WHO itself is the network host.
Using the DALY model, 84% of the funding WHO allocates to research goes to DALY Type I diseases (communic-
able, maternal, perinatal and nutritional diseases) which represents 40% of DALY. 4% is allocated to Daly Type II
(non-communicable diseases) which contributes to 48% of DALY.
45% of WHO permanent staff are involved with health research and the WHO’s approach to research is predomi-
nantly focused on policy, advocacy, health systems and population based research. The Organization principally
undertakes secondary research using published data and commissions others to conduct this work through con-
tracts or research grants. This approach is broadly in line with the stated strategy of the Organization.
Conclusions: The difficulty in undertaking this survey highlights the complexity of obtaining an Organization-wide
assessment of research activity in the absence of common standards for research classification, methods for priority
setting and a mechanism across WHO, or within the governance of global health research more generally, for
managing a research portfolio.
This paper presents a strategic birds-eye view of the WHO research portfolio using methodologies that, with
further development, may provide the strategic information required if there is to be balancing of research efforts
between communicable disease, non-communicable disease and other pressing public health needs. As the rollout
of the WHO strategy on research for health proceeds we would hope to see similar exercises undertaken at the
WHO Regional Offices and in support of capacity building of national health research systems within Member
States.
Background
In May 2010 the World Health Assembly adopted a
resolution (WHA63.21) setting out WHO’sr o l e sa n d
responsibilities in health research and endorsing the
WHO Strategy on Research for Health [1]. One element
of the strategy was to provide an overview of the
research activities WHO is associated with. This report
outlines the findings of the first overview in order to
provide a measure of WHO’s organizational role in sup-
porting primary and secondary research and research
capacity building; and to facilitate a comparative analysis
of research activity between programmes.
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Acronyms
The acronyms used in the text are defined in Table 1.
The term ‘department’ is used for convenience as a col-
lective term to describe an operational unit at WHO.
These operational units or departments can be orga-
nized as programmes, partnerships or alliances. It is
important to note the range in size of these operational
units from 1-2 staff undertaking research within a
WHO programme to departments where research is the
primary focus.
Definitions of Research
After consultation with WHO departments and staff, the
WHO Strategy on Research for Health defined research
as the development of knowledge with the aim of
understanding health challenges and mounting an
improved response to them. This definition covers a
spectrum of research, which spans five generic areas of
activity: measuring the problem; understanding its cause
(s); elaborating solutions; translating the solutions or
evidence into policy, practice and products; and evaluat-
ing the effectiveness of solutions.
In each of these generic areas we used the term pri-
mary and secondary research where secondary research
is research that uses existing data through analysis and/
or synthesis and primary research is activity that gener-
ates new - primary - data. There is no intended hierar-
chy in the terms; both are essential activities to generate
new knowledge.
The term “research WHO is associated with” was
carefully chosen as it covers the different types of inter-
action WHO has with research. These associations
include research that WHO manages directly defined as
conducted research (often by WHO staff) and the
research WHO commissions others to undertake. Com-
missioned research includes: contract research where
the research question is defined by WHO; and the
research that WHO manages indirectly following open
competition, either funding through grants to indivi-
duals or institutions or fellowships. In addition there are
situations where the Organization plays a technical or
advisory role in guiding the research often as part of a
network or partnership. Finally this definition also cov-
ers those activities concerned with research stewardship
functions, policy creation and advocacy.
The focus of the research areas were categorized
further using the following definitions agreed with the
departments:
Basic science research
laboratory based, molecular or genetic, for example vac-
cine development.
Clinical
health research involving human participants most typi-
cally as a clinical trial. This is defined within WHO as
any research study that prospectively assigns human
participants or groups of humans to one or more
health-related interventions to evaluate the effects on
health outcomes. Interventions include but are not
restricted to drugs, cells and other biological products,
surgical procedures, radiological procedures, devices,
behavioural treatments, process-of-care changes, preven-
tive care, etc.
Health services/health systems research
examination of recipients of care, health financing and
administration, health service delivery and the structure
of health care systems.
Population based research
the examination of individuals within a larger scale,
examining the social determinants of health, looking at
the impact of environment on health, larger commu-
nity-based research and cohort studies.
Policy and advocacy
research to understand the transformation of evidence
into practice, how evidence can best be used to improve
public health.
For the purposes of this report the activity of routine
collection of data for surveillance was not included as a
research activity. The use of such data for research pur-
poses is included.
Survey questionnaire and other sources of information
T h es u r v e yq u e s t i o n n a i r ew a sc o m p l e t e db y3 5W H O
departments based at the Geneva headquarters and two
major research institutes where WHO has direct invol-
vement in the governance arrangements: the Kobe Cen-
tre for Health and Development in Japan and the
International Agency for Research on Cancer (IARC) in
France. The surveys were completed during 2008 and
follow up work continued until May 2009. Each depart-
ment provided answers to cover the two year budget
(biennium) for 2006/07. WHO regional offices and col-
laborating centres were not covered by the survey.
The information collected in the questionnaire was
supplemented with published reports, information taken
from the central financial and administrative databases
of WHO and by conducting interviews with the Director
of each department or senior members of staff nomi-
nated by them.
Expenditure and Sources of funding (Figures 1 and 2)
The data was compiled from the sources described
above.
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Research Area WHO
Department
Acronym
§Global
DALY
Type
Research
Expenditure
($US)
Number of
projects
supported
*Staff
Involved
in research
Total
staff
HIV/AIDs, TB, Malaria and
Neglected Tropical Diseases
HIV/AIDS HIV/AIDS I 4,500,000 n/a 31 57
Global Malaria Programme GMP I 1,350,000 n/a 5 23
Stop TB Department STB I 9,100,000 n/a 25 114
Control of Neglected Tropical
Diseases
NTD I 1,300,000 n/a 10 31
Subtotal 63,350,000 n/a 71 225
Health System and Services Alliance for Health Policy & Systems
Research
Alliance
HPSR
IV 3,540,000 30 4 4
Health System Governance &
Service Delivery
HDS IV 1,006,800 n/a 6 20
Health System Financing HSF IV 172,000 n/a 4 19
World Alliance for Patient Safety
programme
PSP IV 500,000 27 5 17
Human Resources
for Health
HRH IV 1,500,000 n/a 5 16
Essential Health Technologies EHT IV 100,000 6 2 19
Essential Medicines &
Pharmaceutical Policies
EMP IV 1,600,000 n/a 40 85
Subtotal 8,418,800 63 66 180
Health Actions in Crisis Emergency Preparedness and
Capacity Building
EPC III 5,600,000 n/a 3 4
Emergency Response and
Operations
ERO III 100,000 n/a 4 11
Recovery and Transition
Programmes
REC III N/A n/a 6 17
Subtotal 5,700,000 n/a 13 32
Information, Evidence and
Research
Health Statistics and Informatics HIS IV 2,000,000 1 5 34
Research Policy and Cooperation RPC IV 917,012 0 4 4
Ethics, Equity, Trade & Human
Rights
ETH IV 30,000 6 4 21
Health Metrics Network HMN IV N/A 6 13 13
Knowledge Management and
Sharing
KMS IV 0 0 0 64
Subtotal 2,947,012 13 26 136
Family and Community
Health
Child & Adolescent Health &
Development
CAH I 5,600,000 39 16 26
Gender, Women and Health GWH I 598,891 n/a 4 5
Immunization, Vaccines and
Biologicals
IVB I 5,000,000 n/a 18 73
Reproductive Health & Research RHR I 32,000,000 35 36 62
Making Pregnancy Safer MPS I 1,000,000 n/a 7 20
Initiative for Vaccine Research IVR I 20,000,000 25 17 18
Polio Eradication Initiative POL I 2,500,000 20 11 38
Subtotal 66,698,891 119 109 242
Noncommunicable Diseases
and Mental Health
Chronic Diseases and Health
Promotion
CHP II 4,000,000 27 10 80
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The Organizational radar diagrams were generated by
asking the departments to provide an estimate of its
scale of support (either low 1, some 2 or strong 3) in
two areas: the type of approach used in funding research
(contracted vs. commissioned) and the nature of the
support across a range of defined research areas. These
estimates were then aggregated across all the depart-
ments and normalised to a 0-100 scale where low sup-
port = 0 - 33; some support = 34 - 66 and strong
support = 67 - 100. Therefore, a score of over 67 repre-
sents the majority of the departments reporting strong
support in this area. The diagram affords equal weight
to each departmental response, so it is important to
note the radar diagram provides a visual representation
of the current strategy taken by the Organization as a
whole. It does not quantify the output of that approach;
it does not include a weighting measure such as disper-
sion of research funds. Furthermore, a department could
record strong support in more than one area as the
areas are not mutually exclusive.
The strategic shape of research at WHO the ‘bubble’
diagram (Figure 5)
Departments were asked to estimate in percentage terms
the degree to which the research they were associated with
was either primary or secondary research (x-axis) and
further to define whether they were conducting or com-
missioning the research (y-axis). The results were then
grouped into research areas and plotted against these two
axes taking the higher percentage figure in each set as the
coordinates. The diameter of the bubble is in proportion
to the research funds it dispersed in 2006/07.
Comparing the research WHO is associated with against
the global burden of disease estimated by disability
adjusted life years 2004 - DALYs (Figure 6) [2]
In order to undertake this comparison we followed the
method outlined by Stuckler et al in their paper on
WHO’sb u d g e t a r ya l l o c a t i o n sa n dt h ee s t i m a t e so ft h e
global burden of disease [3]. We grouped the research
WHO is associated with into four categories: type I infec-
tious disease; type II non-communicable diseases and
type III injuries and violence. These correspond to the
W H Od i s e a s ea n di n j u r yD A L Yt y p e s .T h e r ew e r ea l s oa
number of departments that conduct research for which
there is no corresponding estimate of DALYs. We called
this group ‘capacity’ and this includes the departments
working on health and research policy and systems, the
health workforce, health financing, essential medicines
and technologies, public health and patient safety.
To quantify the WHO response in each category, we
compared the DALYs with the percentage of funding
and the percentage of professional staff allocated to that
Table 1 Research at WHO - data provided for the biennium budget 2006/07 (Continued)
Violence & Injury Prevention &
Disability
VIP III 715,000 3 10 16
Mental Health & Substance Abuse MHS II 15,000 2 4 15
Nutrition for Health & Development NHD I 1,000,000 4 7 18
Tobacco Free Initiative TFI II 2,000,000 n/a 17 35
WHO Centre for Health and
Development, Kobe
WHO
Kobe
Centre
IV 2,400,000 6 6 10
Subtotal 10,130,000 42 54 174
Health Security and
Environment
Epidemic and Pandemic Alert
Response
EPR I N/A 32 30 107
Food Safety, Zoonoses & Food
borne Diseases
FOS I 400,000 17 8 15
Protection of the Human
Environment
PHE I 8,460,000 75 32 44
Subtotal 8,860,000 124 70 166
Special Programme for Research
and Training in Tropical Diseases
TDR I 44,600,000 642 38 43
International Agency for Research
on Cancer
IARC II 51,400,000 210 102 115
TOTAL 215,004, 703
(n = 34)
1213
(n = 22)
549
(n = 37)
1313
(n =
37)
§ Global DALY Types: I Communicable disease, maternal, perinatal and nutritional diseases; II: Noncommunicable diseases; III: Injuries, war and violence. Type IV:
Capacity is not a DALY Type and defined by the authors within this paper.
* Source: Questionnaire response plus WHO Staff Directory includes temporary and fixed term staff and excludes interns collated May 2008.
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ing IARC, as this represents a large proportion of
resource dedicated to cancer and tended to obscure the
findings in other areas.
Limitations of this report
All of the information obtained for the overview is that
reported by the departments themselves and while clari-
fication was sought on a number of points it is without
independent verification. Many of the departments’
responses are subjective and are qualitative judgements
made by one or two senior individuals within a depart-
ment. Efforts were made to standardize the responses
across the departments, but it is important to recognize
there is a large range in the degree of research activity
within WHO, from those departments with a dedicated
research focus dispersing millions of dollars, e.g. RHR/
HRP and TDR, to departments where research is only
one element of their total workplan.
In many programmes research activities are embedded
within operational activities and the boundary between
research and operation activities is difficult to disaggre-
gate. As a result a number of departments were unable
to exactly quantify the specific number of ‘research pro-
jects’ but counted projects which contained an element
of research. For similar reasons no attempt was made to
describe, at a departmental level, the research funded
through core budget provided by Member States and
that funded by extra-budgetary sources, Member States
and other donors. These limitations remain areas for
improvement in future overviews.
Results and discussion
A questionnaire response was obtained from all 37
departments covered by the survey 100% (Table 1. n =
37). However, the response rate for individual questions
varied and this is noted in the text.
Of the 37 departments surveyed 36 reported an element
of research activity. KMS which includes the library,
eHealth initiatives and WHO Press, did not report any
research activities. The two research centres (IARC and
Kobe) and 5 of the departments (Alliance HPSR, IVR,
RHR, RPC and TDR) report that research is their primary
activity. Of the staff included in the survey, 45% (549 out
of a total 1208) are reported as being involved in research
under the strategy’s definition with 13 departments having
more than half their staff involved in research.
The total amount of research expenditure in 2006/07
(n = 34) was US$215 million. Excluding the two research
centres, the total was US$161 million (Figure 1). Figures
were not available from Epidemic & Pandemic Alert &
Response, Recovery & Transition Programmes and the
Health Metrics Network. Within headquarters (excluding
IARC and Kobe) more than half of this funding is
dispersed by 3 departments: the Initiative for Vaccine
Research; Reproductive Health and Research within the
Family and Community Health cluster; and the Special
Programme for Training and Disease Research (TDR).
These 3 departments contain 21% of the staff involved in
research.
The remaining departments at headquarters (n = 29) each
reported expenditure of US$9 million or less, with 13
reporting individual expenditure of under US$1 million.
However, it is worth noting these 29 departments contain
nearly 80% of the staff reported to be involved with research.
The source of funds
The findings are that 20% of funding for the research that
WHO is associated with comes from within the UN sys-
tem. As such, 80% is from other sources, the main two
being government funding agencies (40%) and NGOs,
foundations and charities (27%). The remaining sources
are private (industry) 7% and academia 5% (Figure 2).
The 80% of funding that is not from within the UN
system is considered voluntary contributions, which the
departments often apply for. Therefore, the majority of
research funds WHO disperses are designated funding
that are earmarked for specific projects creating a close
association between the donors that support WHO and
the research WHO supports.
Partnerships
While the total sum of money WHO distributes is mod-
est compared to global figures, WHO rarely operates in
isolation and every department reported that its work
was often undertaken as part of an alliance, partnership
or research network. The survey found that WHO is
involved in more than 60 networks and often WHO
itself is the network host. The survey does not measure
the leverage effect of WHO funding, but this finding
suggests it is considerable.
How the research money is distributed
WHO has two main approaches to the distribution of
research funding. Research is commissioned through
contracts or distributed as grants through open propo-
sals to projects, to institutions or individuals as fellow-
ships or travel awards (Figure 3).
T h ef i g u r es h o w st h a t ,f o rt h eO r g a n i z a t i o na sa
whole, the main funding approaches are for commis-
sioned research contracts and research grants awarded
in response to an open call. Funding for individuals is
only reported as strong by the IARC and a limited num-
ber of fellowships were available through RHR and TDR.
Research areas supported by WHO
Departments described the degree of support they have
for 5 different research areas: basic science, clinical,
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advocacy. This information was aggregated to provide an
overview of the Organization’s research areas (Figure 4).
This diagram illustrates that the approach towards
research at an Organizational level is focused on policy
and advocacy, health services and systems research and
population based research. Considering the mission of
the Organization, this might be expected.
Basic and clinical research tends to be supported in
those departments with research as a major activity or
primary focus and includes TDR, IARC, RHR, IVR
CAH, NTD, FOS and GMP. It is in the basic and clini-
cal areas where the majority of resources to support
research are spent.
The strategic overview of research at WHO the ‘bubble’
diagram (Figure 5)
Figure 5 represents the research approach taken by
WHO in relation to primary and secondary research,
plotted against whether the research is directly managed
by WHO or commissioned, i.e. undertaken by others.
The diagram provides a visual representation to enable
Figure 1 WHO Health Research Expenditure $USD millions 2006/07 (n = 34).
Figure 2 Sources of research funds utilized by WHO 2006/07 (n = 37).
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whole. It poses the question: should the Organization be
evenly spread across all quadrants of the graph or con-
centrated in one area e.g. the bottom right hand corner
- primarily commissioning secondary research?
In 2006/07, WHO research is found in all four quad-
rants, showing there is support across primary and sec-
ondary research that is both commissioned by the
Organization and managed by it. The majority of the
departments are shown as having a higher percentage of
support for secondary research.
Comparing the research WHO is associated with against
the global burden of disease estimated by disability
adjusted life years for 2004
Comparing research expenditure 2006/07 to the
DALYs for 2004 (Figure 6) shows that, when IARC is
excluded, 84% of WHO’sr e s e a r c hb u d g e ti sa l l o c a t e d
to type I diseases that accounts for 40% of estimated
DALYs. 4% of the research budget is allocated to type
II Non-communicable disease that accounts for 48% of
estimated DALYs. 4% of the research budget is allo-
cated to type III Injuries, war and violence that
accounts for 12% of estimated DALYs. In capacity (our
definition) 8% of the budget is allocated, with no esti-
mation for DALYs.
When a comparison is made of the number of staff
allocated to research in these DALYs, a similar pattern
is evident, with a greater proportion of staff associated
with research in DALY type I diseases (66% excluding
IARC) than in type II (7% excluding IARC).
Geographical spread of research projects
For many departments, research is not a discrete activity
but is embedded within the programmes. When asked
to identify the number of separate research projects the
departments were supporting this proved difficult to
obtain. There were 22 departments that provided an
estimated figure, which identified 1213 supported pro-
jects. In this sample 92% of the projects are operational
outside of OECD countries (Table 2).
Of the departments that responded, 13 reported that
the principal investigator was from an OECD country in
108 (36%) projects out of a total of 299 supported by
these 13 departments, and 24 of these projects were
based in an OECD country (8%).
Figure 3 Research funding distributed by WHO - HQ 2006/07. Total $215 million (n = 35).
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Page 7 of 10Figure 4 Research areas supported by WHO-HQ 2006/07 (n = 35).
Figure 5 Overview of Research at WHO 2006/07 (n = 36).
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current activity but indicate that the majority of WHO
support for research is in the middle and low income
countries, led by researchers based in those countries.
Conclusions
In varying degrees, research activity is found throughout
the operational departments based at WHO headquarters
and nearly half of the staff (45%) are involved in research
activities as defined here.
When asking staff for their opinion, the strategic ‘shape’
of the organizational-level approach to research is focused
on policy, advocacy, health systems and population based
research. WHO principally undertakes secondary research
using published data and commissions others to undertake
this work through contracts or research grants. This
Professional Staff involved in Research ( 2006/2007 ) compared to DALY 2004
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Figure 6 Comparison of WHO -HQ Research with DALYs.
Table 2 Number of projects and geographical spread
Total
Number of projects supported 1213 (n = 22)
a
Number of projects led by a Principal Investigator from an OECD country 108 in 299 projects (n = 13)
b
Number of projects operational in an OECD country 24 in 299 Projects (n = 11)
b
a Includes IARC but data for 15 departments was not available
b Excludes IARC
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Organization as a whole. These departments work within
over 60 research networks. This suggests that while WHO
funds for supporting research are modest compared to
global resources, the leverage effect of being an active
partner in the research effort is considerable.
When research activity is assessed by examining
resources, the majority of the research budget WHO dis-
perses is funding primary research in basic and clinical
areas, product development and vaccine initiatives. Using
the DALY model, 84% of the funding WHO allocates to
research goes to Type I diseases (communicable, maternal,
perinatal and nutritional diseases) which represents 40% of
DALY. Only 4% of funding is allocated to Type II (non-
communicable diseases) which contributes to 48% of
DALY. This unequal spread of resources might be a reflec-
tion that basic and clinical research in the Type I diseases
is disproportionately more expensive than that for the
Type II area. However, the picture is the same for the
number of staff allocated to research in this area and tends
to support the findings of others that the allocation of
WHO resources is skewed towards infectious disease [3].
This situation is compounded by the observation that the
majority of funds WHO disperses (80%) is designated
funding earmarked for specific projects. This means there
is a close association between the goals of the donors that
support WHO and the research WHO supports.
These conclusions are similar to those previously iden-
tified in a less comprehensive study conducted by Sida in
2005 and by stakeholders consulted during the develop-
ment of the WHO Strategy on Research for Health [1,4].
Within that strategy, the Goal focusing on the Organiza-
tion seeks to address these issues where it states that
WHO working with Member States and partners will:
‘...establish appropriate structures for keeping abreast
of latest developments in knowledge management, inter-
action with the global research community, and leading,
managing and coordinating research within WHO, and
for maintaining accountability for such research; and
secure the resources needed to support the implementa-
tion and evaluation of this strategy.’
The implementation of the strategy will provide a
strong opportunity to build on the findings presented
here and to institutionalize the regular collection, analy-
sis and communication of such data and ultimately
translate research evidence into practice that has a mea-
sureable impact on improving health.
The difficulty in undertaking this survey and the length of
time required to extract these data highlights the complex-
ity of obtaining an organization-wide assessment of research
activity. This situation is reflective of efforts in global health
more generally, the governance of which has been described
as chaotic [5]. There are no common standards for research
classification, methods for priority setting and no
mechanism across WHO, or within the governance of glo-
bal health research more generally, for managing a research
portfolio as a whole. More importantly if there is to be
greater harmonization of global research activities, as called
for by Health Ministers in Bamako in 2008, more work will
need to be done in identifying such common approaches to
allow for comparable data and benchmarks to manage,
organize or evaluate the global research portfolio [6]. This
paper presents a birds-eye view using methodologies that,
with further development, may assist with evaluations of
that kind in the future. It should also provide the strategic
information required if there is to be balancing of research
efforts between communicable disease, non-communicable
disease and other pressing public health needs. As the roll-
out of the WHO strategy on research for health proceeds
we would hope to see similar exercises undertaken at the
WHO Regional Offices and in support of capacity building
of national health research systems within Member States.
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